Q2 2013

Source filing unavailable

Q2 2013 · —

Revenue

$149.14M

+21.4% vs Q2 2012

Net Income

$35.04M

+23.8% vs Q2 2012

EPS Diluted

$0.42

+27.3% vs Q2 2012

Operating Income$55,586,000+22.3%

Operating Cash Flowderived$22,114,000−19.7%

Same quarter

Metric	Q2 2013	Q2 2012	Q2 2011	Q2 2010
Revenue	$149.14M	$122.81M	$100.44M	$92.77M
Net Income	$35.04M	$28.30M	$24.19M	$35.36M
EPS Diluted	$0.42	$0.33	$0.26	$0.36

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Myriad Genetics Inc · CIK 899923 · Engraved from SEC EDGAR